NO20014022D0 - Anvendelse av kjonnshormoner for a oppna en nasal farmasoytisk sammensetning som er nyttig i behandlingen av uonsketlivmorblodning - Google Patents

Anvendelse av kjonnshormoner for a oppna en nasal farmasoytisk sammensetning som er nyttig i behandlingen av uonsketlivmorblodning

Info

Publication number
NO20014022D0
NO20014022D0 NO20014022A NO20014022A NO20014022D0 NO 20014022 D0 NO20014022 D0 NO 20014022D0 NO 20014022 A NO20014022 A NO 20014022A NO 20014022 A NO20014022 A NO 20014022A NO 20014022 D0 NO20014022 D0 NO 20014022D0
Authority
NO
Norway
Prior art keywords
treatment
pharmaceutical composition
composition useful
uterine bleeding
sex hormones
Prior art date
Application number
NO20014022A
Other languages
English (en)
Other versions
NO20014022L (no
Inventor
Yannis Tsouderos
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO20014022L publication Critical patent/NO20014022L/no
Publication of NO20014022D0 publication Critical patent/NO20014022D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
NO20014022A 1999-03-31 2001-08-17 Anvendelse av kjonnshormoner for a oppna en nasal farmasoytisk sammensetning som er nyttig i behandlingen av uonsketlivmorblodning NO20014022D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9904022A FR2791572A1 (fr) 1999-03-31 1999-03-31 Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables
PCT/FR2000/000790 WO2000059447A2 (fr) 1999-03-31 2000-03-30 Utilisation d'hormones sexuelles pour l'obtention d'une composition pharmaceutique nasale utile pour le traitement des saignements uterins indesirables

Publications (2)

Publication Number Publication Date
NO20014022L NO20014022L (no) 2001-08-17
NO20014022D0 true NO20014022D0 (no) 2001-08-17

Family

ID=9543854

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20014022A NO20014022D0 (no) 1999-03-31 2001-08-17 Anvendelse av kjonnshormoner for a oppna en nasal farmasoytisk sammensetning som er nyttig i behandlingen av uonsketlivmorblodning

Country Status (16)

Country Link
EP (1) EP1143978A2 (no)
JP (1) JP2002541076A (no)
KR (1) KR20010102464A (no)
CN (1) CN1346273A (no)
AU (1) AU3662300A (no)
BR (1) BR0008577A (no)
CA (1) CA2361885A1 (no)
EA (1) EA200100801A1 (no)
FR (1) FR2791572A1 (no)
HK (1) HK1044486A1 (no)
HU (1) HUP0200244A3 (no)
NO (1) NO20014022D0 (no)
NZ (1) NZ513672A (no)
PL (1) PL356767A1 (no)
WO (1) WO2000059447A2 (no)
ZA (1) ZA200106689B (no)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4383993A (en) * 1980-05-30 1983-05-17 University Of Kentucky Research Foundation Nasal dosage forms containing natural female sex hormones
NL8801670A (nl) * 1988-07-01 1990-02-01 Walter Adrianus Josephus Johan Farmaceutisch preparaat.
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
WO1998003207A1 (en) * 1996-07-23 1998-01-29 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety

Also Published As

Publication number Publication date
PL356767A1 (en) 2004-07-12
AU3662300A (en) 2000-10-23
JP2002541076A (ja) 2002-12-03
WO2000059447A3 (fr) 2001-04-26
EP1143978A2 (fr) 2001-10-17
NZ513672A (en) 2001-09-28
HUP0200244A3 (en) 2003-05-28
WO2000059447A2 (fr) 2000-10-12
BR0008577A (pt) 2002-10-01
NO20014022L (no) 2001-08-17
ZA200106689B (en) 2002-11-14
HUP0200244A2 (hu) 2002-07-29
HK1044486A1 (zh) 2002-10-25
EA200100801A1 (ru) 2002-04-25
CN1346273A (zh) 2002-04-24
KR20010102464A (ko) 2001-11-15
FR2791572A1 (fr) 2000-10-06
CA2361885A1 (fr) 2000-10-12

Similar Documents

Publication Publication Date Title
EE200200535A (et) Konjugeeritud östrogeenide ja medroksüprogesteroonatsetaadi kasutamine, farmatseutiline kompositsioon, doseerimisühik ja pakend
DK1158992T3 (da) Anvendelse af xenon til fremstilling af et farmaceutisk præparat til behandling af neurointoksikationer
ITRM910922A1 (it) Composizione farmaceutica anticefalalgica per somministrazione endonasale, procedimento per prepararla e suo impiego terapeutico
EE05378B1 (et) LahustuvaÁCTLA4ÁsulandmolekuliÁkasutamineÁravimkoostiseÁvalmistamiseks
CY2011014I1 (el) Φαρμακοτεχνικες μορφες σταθερου φαρμακευτικου διαλυματος για υπο πιεση μετρημενης δοσης συσκευες εισπνοης
DK1079807T3 (da) Anvendelse af præparater til tilförsel af antiseptiske midler og/eller midler, som fremmer heling af sår, til de nedre luftveje
EE04997B1 (et) Loteprednooli ja antihistamiinseid aineid sisaldav farmatseutiline kompositsioon, neid aineid sisaldav ravim, meetod selle ravimi valmistamiseks ja nende ainete kombinatsiooni kasutamine
IL167250A (en) Chirale oxazole-arylpropionic acid derivatives, compositions comprising thereof and their use in the preparation of medicaments for the treatment of ppar alpha/ ppar gamma agonists-modulated diseases
DK1225902T3 (da) Ciclesonidholdigt farmaceutisk præparat til administration til slimhinden
DE60218375D1 (de) Pharmazeutische Zusammensetzung zur Behandlung gynäkologischer Erkrankungen
NO20025394L (no) Formuleringer inneholdende et glukokorticoid legemiddel for behandling av bronkopulmon¶re sykdommer
IS6172A (is) Notkun melatoníns til lækninga
DK1150681T3 (da) Anvendelse af en farmaceutisk sammensætning indeholdende desoxypeganin til behandling af nikotinafhængighed
NO20026055L (no) Farmasöytiske komponenter innbefattende humant paratyreoideahormon og farmasöytiske sammenstninger for nasal administrering inneholdendekomponentene
NO20014022D0 (no) Anvendelse av kjonnshormoner for a oppna en nasal farmasoytisk sammensetning som er nyttig i behandlingen av uonsketlivmorblodning
EE05317B1 (et) Etinl”stradiooli ja drospirenooni sisaldav farmatseutiline kompositsioon kasutamiseks rasestumisvastase vahendina
EE200200551A (et) Oligosahhariide sisaldav farmatseutiline kompositsioon, oligosahhariidid, nende valmistamine ja raviotstarbeline kasutamine
IL137275A0 (en) Pharmaceutical composition for the treatment of anal fissures
GB0026923D0 (en) Veterinary composition for the topical treatment of traumatized or inflamed skin
IT1320192B1 (it) Composizione terapeutica per la cura della psoriasi.
AR030945A1 (es) Amidas de acido fenilciclohexanocarboxilico sustituido y su uso
ITMI20001053A0 (it) Derivati 2-amminotetralinici otticamente attivi, procedimenti per la loro preparazione e impiego terapeutico delle corrispondenti composizio
IT1312060B1 (it) Uso dell'acido alfa lipoico nel trattamento antimetastatico.
HUP0300876A3 (en) Use of diclofenac for the manufacture of medicament for the topical treatment of burns
DK1227811T3 (da) Anvendelse af 2-imidazol-substituerede carbinoler til fremstilling af et lægemiddel til behandling eller profylakse af sygdomme fremkaldt af iskæmiske tilstande

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application